This is Neil Woodford’s take on Imperial Brands’ share price drop

Imperial Brands plc’s (LON: IMB) share price has taken a beating over the last 18 months. Here are Neil Woodford’s thoughts on the stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Imperial Brands’ (LSE: IMB) share price has suffered an extraordinary decline over the last 18 months. Back in September 2016, it was a FTSE 100 company that everyone wanted to own. The stock had risen spectacularly over a five-year period and was trading above 4,000p. However, since then, sentiment towards the £22bn market cap tobacco manufacturer has changed dramatically, with the shares today changing hands under 2,400p today.

At that price, Imperial trades on a forward-looking P/E ratio of under 9, and sports a dividend yield of around 8%. So what on earth is going on? Is the FTSE 100 stock a bargain or is the company in trouble?

Here’s fund manager Neil Woodford’s take.

The wrong price

He believes the market has got it wrong with Imperial. In a February update, Woodford Investment Management posted the following comment on its website in relation to the tobacco giant:

Current market conditions have not been favourable for Imperial Brands, which has been a deeply unpopular stock. Nevertheless, from a fundamental perspective, Imperial Brands continues to be a business which should deliver attractive and sustainable long-term dividend growth, as it has done throughout its history as a quoted, independent business. With the share price revisiting valuation territory that we haven’t seen in many years, Imperial Brands simply looks like it is trading at the wrong price.”

Furthermore, in relation to Imperial’s February AGM statement, Woodford Investment Management commented: “Overall, the update is as expected and it suggests that the business is in far better shape than its share price and valuation would suggest.”

Clearly, Woodford and his team believe that Imperial is oversold at present. And it appears that they are not afraid to put their money where their mouths are. Imperial is currently the top holding in both Woodford’s Equity Income Fund and his Income Focus fund with weightings of 6.75% and 6.96% respectively.

So, has he got it right or could this turn out to be another disaster like Provident Financial?

Oversold

While I don’t always agree with Woodford’s calls, I believe that on this occasion he has got it right. Imperial simply looks way oversold at current levels.

There are no doubt concerns about the long-term profitability of the industry, but the fact remains that Imperial is a cash generative business capable of paying out sizeable dividends to shareholders. In its recent AGM statement, the group advised that “cash generation remains strong, underpinning our 10% growth. ”

Imperial’s dividend growth track record is outstanding, having recorded nine consecutive dividend increases of 10% now. And with a payout ratio of 64% last year, the dividend does not look at risk.

For me, a classic contrarian indicator here is last week’s downgrade from Goldman Sachs in which the investment bank cut its stance on Imperial from ‘buy’ to ‘neutral.’ I find this quite incredible. Surely, it would have been more appropriate to downgrade the stock to neutral when it was trading above 4,000p, and not after a 40% share price decline?

For long-term investors, today’s share price and dividend yield look to offer strong long-term value, in my opinion.

Edward Sheldon owns shares in Imperial Brands. The Motley Fool UK has recommended Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »